Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: HPBCD

December 9, 2021 Non-pharma applications / Pharma applications

Barentz Acquires Gangwal in India

Barentz International, a leading global life science ingredients distributor announced an agreement to acquire a majority stake in the distribution

Continue reading

photo of doctor holding x ray result
December 8, 2021 Drug delivery / Pharma applications

HPBCD solubilized pazopanib against lung injuries due to coronavirus infection

Professor Wu Dianquing at Yale university has discovered that a widely used anticancer drug, pazopanib might be suitable for treating

Continue reading

December 7, 2021 CD as API / CD derivatives / Pharma applications

Cyclo Therapeutics Receives IND Clearance from the U.S. FDA to Advance its Phase 2 Study of Trappsol® Cyclo™ for the Treatment of Alzheimer’s Disease

Cyclo Therapeutics, Inc. (Nasdaq: CYTH) (“Cyclo Therapeutics” or the “Company”), a clinical stage biotechnology company dedicated to developing life-changing medicines through

Continue reading

November 30, 2021 CD derivatives / Life sciences

Cyclodextrins Exert a Ligand-like Current Inhibitory Effect on the KV1.3 Ion Channel Independent of Membrane Cholesterol Extraction

Effects of CDs exerted on cellular functions are generally thought to originate from reductions in cholesterol levels. Potential direct, ligand-like

Continue reading

November 18, 2021 CD as API / CD derivatives / Pharma applications

Cyclo Therapeutics Submits IND Application to U.S. FDA to Advance Trappsol® Cyclo™ in Phase 2 Study for Treatment of Alzheimer’s Disease

Cyclo Therapeutics, Inc., a clinical stage biotechnology company dedicated to developing life-changing medicines through science and innovation for patients and

Continue reading

November 11, 2021 Life sciences / Pharma applications

Role of HPBCD in development of Pfizer’s novel COVID-19 oral antiviral treatment candidate

Pfizer’s breakthrough drug candidate PF-07321332 used in combination with ritonavir was poven to successfully reduce the risk of hospitalization and

Continue reading

October 21, 2021 CD as API / Pharma applications

Parkinson’s Disease Phenotypes in Patient Neuronal Cultures and Brain Organoids Improved by 2-Hydroxypropyl-β-Cyclodextrin Treatment

OrganoTherapeutics in collaboration with University of Luxemburg has published interestingin vitro and in vivo results on the effects of HPBCD

Continue reading

September 27, 2021 Uncategorized

Caffeine, a natural methylxanthine nutraceutical, exerts dopaminergic neuroprotection

Parkinson’s disease (PD) is a progressive neurodegenerative disorder that affects more than 10 million people worldwide. Oxidative stress and mitochondrial

Continue reading

September 24, 2021 CD as API / CD derivatives / Events / Pharma applications

Meet the Experts: Cyclodextrins as active ingredients in the 21st century – Webinar of CycloLab

After the great success of the webinar held in May, 2021 a next webinar organized by CycloLab will be held

Continue reading

September 16, 2021 Drug delivery / Pharma applications

Large ring cyclodextrins for solubilization of Domperidone

Large ring cyclodextrins were prepared and studied as alternatives for drug solubilization [1]. A mixture of CD22-48 was compared with

Continue reading

Posts pagination

«Previous Posts 1 … 19 20 21 22 23 … 31 Next Posts»

Recent Posts

  • β-Cyclodextrin inclusion complexes as supramolecular carriers: Established and emerging applications in the food industry
  • 16th Central European Symposium on Pharmaceutical Technology (CESPT 2027)
  • Paul Janssen was born 100 years ago
  • Adsorption of PFAS to Cationic β-Cyclodextrin Polymers
  • A cyclodextrin polymer that could change the future of batteries

Tags

alpha-CD atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Sugammadex Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (27)
  • Analysis (74)
  • CD as API (357)
  • CD derivatives (434)
  • Cosmetics and toilettry (54)
  • Diagnosis (15)
  • Drug delivery (818)
  • E-ducation (63)
  • Environmental (144)
  • Events (241)
  • Food (235)
  • Gene delivery (22)
  • Household products (6)
  • In Hungarian (4)
  • Life sciences (45)
  • Non-pharma applications (418)
  • Other industrial use (113)
  • Pharma applications (1,223)
  • Supramolecular systems (44)
  • Uncategorized (169)

Top Posts

  • β-Cyclodextrin inclusion complexes as supramolecular carriers: Established and emerging applications in the food industry
  • 16th Central European Symposium on Pharmaceutical Technology (CESPT 2027)
  • Phosphorylated Beta-cyclodextrin as a New Bone-Targeting Drug Delivery System Could Change the Treatment of Osteoporosis and Other Bone Diseases
  • How air fresheners work?
  • Cyclodextrins Meet Spicy Food: HOOAGO
  • Lanosterol eye drops for cataract treatment
  • Cyclodextrins Meet Cosmetics, a review
  • Potential Glioblastoma Therapy with Cationic Cyclodextrin Polymers as Drug Delivery Excipients
  • Piroxicam/Cyclodextrin: 35 years on the market
  • Methyl salicylate/methyl-β-cyclodextrin inclusion complex modulates plant defense against cold and heat stress

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,458 other subscribers
Loading Comments...